Brazil Breaks Patent On A Merck Drug | Chemical & Engineering News
Latest News
Web Date: May 8, 2007

Brazil Breaks Patent On A Merck Drug

Despite drug maker's patent on AIDS drug, Brazil plans to import cheaper generic
Department: Government & Policy, Business

Merck & Co. says it is "profoundly disappointed" by Brazil's decision to break the patent on a key AIDS drug made by the U.S. pharmaceutical giant and buy a less expensive generic version of the medicine from India.

On May 4, Brazilian President Luiz In??cio Lula da Silva signed a decree authorizing his country's Ministry of Health to issue a "compulsory license" for efavirenz, a move that allows a country . . .

You Do Not Have Access to C&EN Protected Content.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society